Spleen tyrosine kinase regulates AP-1 dependent transcriptional response to minimally oxidized LDL

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Choi, Soo Ho ^a   Wiesner, Philipp ^a   Almazan, Felicidad ^a   Kim, Jungsu ^a   Miller, Yury I ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS DNA; CXCL2 CHEMOKINE; DNA; I KAPPA B KINASE EPSILON; INTERLEUKIN 6; MINIMALLY OXIDIZED LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOID DIFFERENTIATION FACTOR 88; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE SYK; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; CD14 ANTIGEN; CXCL2 PROTEIN, MOUSE; I KAPPA B KINASE; LOW DENSITY LIPOPROTEIN; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CXCL2 GENE; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; INTERLEUKIN 6 GENE; KNOCKOUT MOUSE; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CHO CELL; CYTOLOGY; GENETIC TRANSCRIPTION; HAMSTER; HUMAN; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD14; BONE MARROW CELLS; CHEMOKINE CXCL2; CHO CELLS; CRICETINAE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; I-KAPPA B KINASE; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84863139252     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032378     Document Type: Article

References (31)

1. Mocsai A, Ruland J, Tybulewicz VLJ, (2010) The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol 10: 387-402.
2. Jakus Z, Fodor S, Abram CL, Lowell CA, Mocsai A, (2007) Immunoreceptor-like signaling by [beta]2 and [beta]3 integrins. Trends in Cell Biology 17: 493-501.
3. Woodside DG, Obergfell A, Talapatra A, Calderwood DA, Shattil SJ, et al. (2002) The N-terminal SH2 Domains of Syk and ZAP-70 Mediate Phosphotyrosine-independent Binding to Integrin Cytoplasmic Domains. J Biol Chem 277: 39401-39408.
4. Bae YS, Lee JH, Choi SH, Kim S, Almazan F, et al. (2009) Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein: Toll-Like Receptor 4- and Spleen Tyrosine Kinase-Dependent Activation of NADPH Oxidase 2. Circ Res 104: 210-218.
5. Choi S-H, Harkewicz R, Lee JH, Boullier A, Almazan F, et al. (2009) Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res 104: 1355-1363.
6. Miller YI, Choi SH, Fang L, Harkewicz R, (2009) Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med 7: 227-232.
7. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, et al. (2009) Vascular Lipid Accumulation, Lipoprotein Oxidation, and Macrophage Lipid Uptake in Hypercholesterolemic Zebrafish. Circ Res 104: 952-960.
8. Miller YI, Choi S-H, Wiesner P, Fang L, Harkewicz R, et al. (2011) Oxidation-Specific Epitopes are Danger Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity. Circ Res 108: 235-248.
9. Saijo K, Schmedt C, Su IH, Karasuyama H, Lowell CA, et al. (2003) Essential role of Src-family protein tyrosine kinases in NF-[kappa]B activation during B cell development. Nat Immunol 4: 274-279.
10. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S, (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
11. Sawka-Verhelle D, Escoubet-Lozach L, Fong AL, Hester KD, Herzig S, et al. (2004) PE-1/METS, an Antiproliferative Ets Repressor Factor, Is Induced by CREB-1/CREM-1 during Macrophage Differentiation. J Biol Chem 279: 17772-17784.
12. Benz DJ, Mol M, Ezaki M, Mori-Ito N, Zelaan I, et al. (1995) Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem 270: 5191-5197.
13. Saitoh S, Akashi S, Yamada T, Tanimura N, Kobayashi M, et al. (2004) Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. International Immunology 16: 961-969.
14. Wong SW, Kwon MJ, Choi AMK, Kim HP, Nakahira K, et al. (2009) Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner. J Biol Chem 284: 27384-27392.
15. Havel RJ, Bragdon JH, Eder HA, (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
16. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, et al. (2003) Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells. J Biol Chem 278: 1561-1568.
17. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, et al. (2005) Toll-like receptor 4-dependent and-independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 25: 1213-1219.
18. Boullier A, Li Y, Quehenberger O, Palinski W, Tabas I, et al. (2006) Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler Thromb Vasc Biol 26: 1169-1176.
19. Wiesner P, Choi SH, Almazan F, Benner C, Huang W, et al. (2010) Low Doses of Lipopolysaccharide and Minimally Oxidized Low-Density Lipoprotein Cooperatively Activate Macrophages via Nuclear Factor {kappa}B and Activator Protein-1. Possible Mechanism for Acceleration of Atherosclerosis by Subclinical Endotoxemia. Circ Res 107: 56-65.
20. Davis RJ, (2000) Signal Transduction by the JNK Group of MAP Kinases. Cell 103: 239-252.
21. Huang W, Ghisletti S, Perissi V, Rosenfeld MG, Glass CK, (2009) Transcriptional Integration of TLR2 and TLR4 Signaling at the NCoR Derepression Checkpoint. Molecular Cell 35: 48-57.
22. Sweeney SE, Hammaker D, Boyle DL, Firestein GS, (2005) Regulation of c-Jun Phosphorylation by the IkappaB Kinase-epsilon Complex in Fibroblast-Like Synoviocytes. The Journal of Immunology 174: 6424-6430.
23. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J, (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 4: 556-564.
24. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, et al. (2005) Phosphorylation of c-Fos by Members of the p38 MAPK Family. J Biol Chem 280: 18842-18852.
25. Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, et al. (2001) Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line. J Exp Med 194: 79-88.
26. Miller YI, (2005) Toll-like receptors and atherosclerosis: oxidized LDL as an endogenous Toll-like receptor ligand. Future Cardiology 1: 785-792.
27. Harkewicz R, Hartvigsen K, Almazan F, Dennis EA, Witztum JL, et al. (2008) Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized LDL. J Biol Chem 283: 10241-10251.
28. Faggioli L, Costanzo C, Donadelli M, Palmieri M, (2004) Activation of the interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1692: 17-24.
29. Ulanova M, Asfaha S, Stenton G, Lint A, Gilbertson D, et al. (2007) Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages. J Endotoxin Res 13: 117-125.
30. Lin YC, Huang DY, Chu CL, Lin WW, (2010) Anti-inflammatory actions of Syk inhibitors in macrophages involve non-specific inhibition of toll-like receptors-mediated JNK signaling pathway. Mol Immunol 47: 1569-1578.
31. Hilgendorf I, Eisele S, Remer I, Schmitz J, Zeschky K, et al. (2011) The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol 31: 1991-1999.